Development and Commercialization of a New Pesticide Pipeline

「・成長製品（殺菌剤「ピシロック」「ミギワ」、殺ダニ剤「ダニオーテ」）の販売が増加」

「The Company continues global development of the new insecticide NI-40, which has a novel mode of action and demonstrates high efficacy against a broad range of pests. The compound is also effective against pests resistant to existing products and is expected to contribute to sustainable agriculture. Research is also under way on next-generation pipeline products following these candidates, with themes selected based on market needs and efforts focused on advancing them through development phases.」

「Demand recovered as distribution inventories returned generally to appropriate levels, leading to increases in fungicides, insecticides and acaricides. As a result, sales for the interim period amounted to ¥19.254 billion, up 15.1% year on year, and operating profit amounted to ¥1.784 billion, up 71.2%.」

「Although exports of Pancho increased, revenue from fungicides declined due to lower exports of Topsin M and delays in Piciroсk exports resulting from the Noto Peninsula Earthquake.」

「The Company is actively pursuing overseas development of Piciroсk, a fungicide demonstrating outstanding efficacy against downy mildew and Pythium diseases. In the United States, it is used for seed treatment of corn and other crops and on golf-course turf, and has been well received. Further sales growth is expected in Asia, including China and India. The new acaricide Danioーテ, which has a novel mode of action, is entering its fourth year after launch and has been well received mainly in Japan and South Korea. For Migiwa, a fungicide effective against a broad range of diseases, sales are expected to gain further momentum following the launch last October of a new formulation for vegetables, after the launch in December 2022 of a formulation for fruit trees sold nationwide. Overseas development is also progressing smoothly, with various trials for registration under way globally. The Company also began global development this year of the new insecticide NI-40.」

「Although sales of the fungicide Migiwa and acaricide Danioーテ increased, sales for the cumulative period amounted to ¥30.613 billion, down 25.6% year on year, due mainly to lower exports of the insecticide Mospilan, fungicide Topsin M and acaricide Nissorun.」

「Exports of insecticides, acaricides and fungicides declined in the first half of the current year due to the impact of front-loaded shipments in the first half of the previous year, prompted by disruptions in global maritime transport and expectations of higher selling prices.」

「Although exports of the proprietary fungicides Migiwa and Piciroсk and acaricide Danioーテ increased, sales for the cumulative period amounted to ¥10.869 billion, down 19.1% year on year, due mainly to lower exports of the fungicides Pancho and Topsin M and acaricide Nissorun.」

「Due to strong overseas demand, exports of the insecticide Mospilan, fungicides Topsin M, Pancho and Piciroсk, and acaricide Nissorun grew, and sales for the cumulative period amounted to ¥41.146 billion, up 44.6% year on year.」

「Fungicide revenue increased as exports of Topsin M, Pancho and Piciroсk grew. Insecticide and acaricide revenue also increased as exports of the insecticide Mospilan and acaricides Nissorun and Danioーテ grew.」

「The new acaricide Danioーテ, which has a novel mode of action, was launched domestically in October 2020 and has been well received. Migiwa, a fungicide effective against a broad range of diseases, was launched domestically in February 2021. Overseas development is also progressing smoothly, and registration was obtained in the United States in March 2022.」

「Although exports of the fungicide Topsin M declined, sales for the cumulative period amounted to ¥28.456 billion, up 4.2% year on year, due mainly to increased exports of the acaricide Nissorun and insecticide Mospilan, as well as the launch of sales of the new acaricide Danioーテ.」

「Although sales of newly developed proprietary pesticides contributed to earnings, exports of fungicides and herbicides declined. For fungicides, sales began for exports of the new fungicide Piciroсk and for the new fungicide Migiwa, but revenue declined due mainly to lower exports of Pancho. For insecticides and acaricides, although exports of the insecticide Mospilan declined, revenue increased due mainly to the launch of sales of the new acaricide Danioーテ.」

「Although exports of the insecticide Mospilan declined, sales for the cumulative period amounted to ¥8.860 billion, up 3.6% year on year, due mainly to increased sales of the new acaricide Danioーテ and other products.」

「The Company will work to rapidly promote and expand sales of the new acaricide Danioーテ, launched domestically in October 2020, and the new fungicide Migiwa, launched domestically in February 2021.」

「Due to increased sales of the insecticide Mospilan and herbicide Conclude, as well as the launch of sales of the new acaricide Danioーテ in October 2020, sales for the cumulative period amounted to ¥27.305 billion, up 4.3% year on year.」

「Global development of Ipflufenoquin (NF-180), a fungicide effective against a broad range of diseases, is progressing smoothly, and domestic registration approval was obtained on 14 July 2020. Registration in countries overseas, including Europe and the United States, is planned.」

「Global development of Ipflufenoquin (NF-180), a fungicide effective against a broad range of diseases, is progressing smoothly, and domestic registration approval was obtained on 14 July 2020. Registration in countries overseas, including Europe and the United States, is planned.」

「The Company will work to expand sales of the new fungicide Piciroсk and steadily advance development and begin sales of the new acaricide Danioーテ and new fungicide NF-180, while increasing sales volumes of existing products.」

「The Company is actively pursuing overseas development, including in Europe and the United States, of Picalbutrazox (NF-171), a fungicide demonstrating outstanding efficacy against downy mildew and Pythium diseases. Applications include foliar spraying on cucurbits and leafy vegetables and seed treatment for crops such as corn. Preparations are also under way for the domestic launch of Acynonapyr (NA-89), an acaricide with a novel mode of action. Development of Ipflufenoquin (NF-180), a fungicide effective against a broad range of diseases, is progressing smoothly, and various trials for registration are under way globally.」

「Although the Company actively promoted awareness-building activities for the new fungicide products in the Piciroсk range, launched in fiscal 2017, and sales activities for existing products, it was affected by rising raw-material and fuel prices.」

「For newly developed proprietary pesticides, Picalbutrazox (NF-171), a fungicide demonstrating outstanding efficacy against downy mildew and Pythium diseases, received registration approval for food-crop applications in July 2017, following registration approval for turf applications in January 2017, and was successfully launched during fiscal 2017. Overseas development is also being actively pursued. Development of the novel-acaricide Acynonapyr (NA-89) is progressing smoothly. The Company completed its domestic registration application in February 2017 and is targeting registration approval in 2019.」

「In July 2017, registration was approved for food-crop applications for 3 fungicide formulations containing Picalbutrazox (NF-171), a new pesticide active ingredient under development. The Company will begin selling them under the product name Piciroсk Flowable in horticulture and, likewise, under the names Naefine Flowable and Naefine Wettable Powder in rice cultivation.」

「For newly developed proprietary pesticides, Picalbutrazox (NF-171), a fungicide demonstrating outstanding efficacy against downy mildew and Pythium diseases, received registration approval for turf applications in January 2017. Registration approval for food crops is expected shortly, and the product is scheduled for launch during the year. Preparations for the production system are also progressing as planned. Overseas development is being actively pursued. Development of the novel-acaricide Acynonapyr (NA-89) is also progressing smoothly. The Company completed its domestic registration application in February 2017 and is targeting registration approval in 2019. Overseas development has also been approved. Development of NF-180, a fungicide effective against a broad range of diseases, is also progressing smoothly.」

「At a meeting of the Board of Directors held on 9 December 2016, the Company resolved to acquire additional shares in Certis Europe B.V., an investee company (hereinafter, “Certis”), making it an equity-method affiliate, and acquired the shares as follows: Date of acquisition: 12 January 2017. Ownership interest after acquisition: 20.0% (15.0% before the additional acquisition). Following this acquisition, the Company positioned Certis as an important partner in Europe and will seek to expand sales of its products and rapidly increase the market share of new pesticides scheduled for launch.」

「R&D expenses associated with the development of new agricultural chemicals scheduled for successive launches from 2017 onward remained at a high level.」

「Development of new agricultural chemicals is progressing smoothly. The company aims to launch the fungicide NF-171 in 2017. It is also proceeding with full-scale development of the acaricide NA-89 and the fungicide NF-180, with the aim of launching them successively.」